PROOF OF THE INVOLVEMENT OF PAF-ACETHER IN PULMONARY COMPLEX IMMUNE SYSTEMS USING A SPECIFIC PAF-ACETHER RECEPTOR ANTAGONIST - BN 52021

被引：1
|
作者：
TOUVAY, C [1 ]
VILAIN, B [1 ]
ETIENNE, A [1 ]
CLOSTRE, F [1 ]
DRIEU, K [1 ]
BRAQUET, P [1 ]
机构：
[1] IHB,RES LABS,F-92350 PLESSIS ROBINSON,FRANCE
来源：
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1985年 / 7卷 / 03期
关键词：
D O I：
10.1016/0192-0561(85)90412-6
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：385 / 385
页数：1
相关论文
共 50 条
  • [1] PROOF OF THE INVOLVEMENT OF PLATELET-ACTIVATING-FACTOR (PAF-ACETHER) IN PULMONARY COMPLEX IMMUNE-SYSTEMS USING A SPECIFIC PAF-ACETHER RECEPTOR ANTAGONIST - BN-52021
    TOUVAY, C
    VILAIN, B
    TAYLOR, JE
    ETIENNE, A
    BRAQUET, P
    PROGRESS IN LIPID RESEARCH, 1986, 25 : 277 - 288
  • [2] THE EFFECTS OF PAF-ACETHER ON THE CARDIOVASCULAR-SYSTEM AND THEIR INHIBITION BY A NEW HIGHLY SPECIFIC PAF-ACETHER RECEPTOR ANTAGONIST BN 52021
    BARANES, J
    HELLEGOUARCH, A
    LEHEGARAT, M
    VIOSSAT, I
    AUGUET, M
    CHABRIER, PE
    BRAQUET, P
    BRAQUET, F
    PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1986, 18 (08): : 717 - 737
  • [3] DOWN-REGULATION OF BETA-2-ADRENERGIC RECEPTORS BY PAF-ACETHER AND ITS INHIBITION BY THE PAF-ACETHER ANTAGONIST BN-52021
    BRAQUET, P
    ETIENNE, A
    CLOSTRE, F
    PROSTAGLANDINS, 1985, 30 (04): : 721 - 721
  • [4] PROTECTIVE EFFECT OF A PAF-ACETHER ANTAGONIST, BN-52021, IN TRICHOTHECENE TOXICOSIS
    FEUERSTEIN, G
    LEADER, P
    SIREN, AL
    BRAQUET, P
    TOXICOLOGY LETTERS, 1987, 38 (03) : 271 - 274
  • [5] ANTIALLERGIC ACTIVITY OF THE SPECIFIC PAF-ACETHER ANTAGONIST BN 52063
    VILAIN, B
    TOUVAY, C
    CARRE, C
    GUINOT, P
    MENCIAHUERTA, JM
    BRAQUET, P
    BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1987, 23 : S376 - S376
  • [6] INHIBITION OF INVIVO AND INVITRO PULMONARY EFFECTS OF PAF-ACETHER BY BN-52021
    TOUVAY, C
    VILAIN, B
    ETIENNE, A
    BRAQUET, P
    PROSTAGLANDINS, 1985, 30 (04): : 719 - 719
  • [7] A SPECIFIC INHIBITOR FOR THE PAF-ACETHER - UTILIZATION OF THE BN-52021 IN BRONCHIAL HYPERSENSITIVENESS
    BRAQUET, P
    GUINOT, P
    TOUVAY, C
    SUMMERHAYES, C
    CLOSTRE, F
    M S-MEDECINE SCIENCES, 1987, 3 (09): : 515 - 521
  • [8] ROLE OF PLATELET-ACTIVATING FACTOR (PAF) IN THE OVOIMPLANTATION IN THE RAT - EFFECT OF THE SPECIFIC PAF-ACETHER ANTAGONIST, BN 52021
    ACKER, G
    HECQUET, F
    ETIENNE, A
    BRAQUET, P
    MENCIAHUERTA, JM
    PROSTAGLANDINS, 1988, 35 (02): : 233 - 241
  • [9] INHIBITION OF TRANSMEMBRANE MOVEMENT AND METABOLISM OF PLATELET ACTIVATING FACTOR (PAF-ACETHER) BY A SPECIFIC ANTAGONIST, BN 52021
    LACHACHI, H
    PLANTAVID, M
    SIMON, MF
    CHAP, H
    BRAQUET, P
    DOUSTEBLAZY, L
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 132 (02) : 460 - 466
  • [10] INHIBITION OF THE VASCULAR ACTIONS OF IGG AGGREGATES BY BN-52021, A HIGHLY SPECIFIC ANTAGONIST OF PAF-ACETHER
    SANCHEZCRESPO, M
    FERNANDEZGALLARDO, S
    NIETO, ML
    BARANES, J
    BRAQUET, P
    IMMUNOPHARMACOLOGY, 1985, 10 (02): : 69 - 75
12345